Agios Pharmaceuticals, Inc. (AGIO) Insider Trading
Over the last 3 months, AGIO insiders made 0 open-market buys and 8 sales, a net sale of -$1.3M (SEC Form 4). Over the last 6 months, 185 institutions increased and 148 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
8
Net (3m)
-$1.3M
Insider trades by month Buys Sells
Sep
Oct
Nov
Jan
Mar
Apr
Context3-month price +4%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 6, 2026 | Goff Briandirector, officer: Chief Executive Officer | Option | 13,500 | — |
| Apr 6, 2026 | Burns James Williamofficer: Chief Legal Officer | Option | 8,500 | — |
| Apr 6, 2026 | Viswanadhan Krishnanofficer: Chief Corp Dev & Strategy | Sell | 2,959 | $34.71 |
| Apr 6, 2026 | Gheuens Sarahofficer: Chief Medical Officer | Option | 8,500 | — |
| Apr 6, 2026 | Viswanadhan Krishnanofficer: Chief Corp Dev & Strategy | Option | 8,100 | — |
| Apr 6, 2026 | Jones Ceciliaofficer: Chief Financial Officer | Option | 8,500 | — |
| Apr 6, 2026 | Goff Briandirector, officer: Chief Executive Officer | Option | 25,528 | — |
| Apr 6, 2026 | Jones Ceciliaofficer: Chief Financial Officer | Sell | 3,141 | $34.71 |
| Apr 6, 2026 | Goff Briandirector, officer: Chief Executive Officer | Sell | 12,472 | $34.71 |
| Apr 6, 2026 | Goff Briandirector, officer: Chief Executive Officer | Sell | 6,596 | $34.71 |
| Apr 6, 2026 | Milanova Tsvetaofficer: Chief Commercial Officer | Sell | 3,262 | $34.71 |
| Apr 6, 2026 | Milanova Tsvetaofficer: Chief Commercial Officer | Option | 8,500 | — |
| Apr 6, 2026 | Burns James Williamofficer: Chief Legal Officer | Sell | 3,280 | $34.71 |
| Apr 6, 2026 | Gheuens Sarahofficer: Chief Medical Officer | Sell | 2,940 | $34.71 |
| Mar 9, 2026 | Viswanadhan Krishnanofficer: Chief Corp Dev & Strategy | Sell | 2,959 | $27.80 |
| Mar 9, 2026 | Viswanadhan Krishnanofficer: Chief Corp Dev & Strategy | Option | 8,100 | — |
| Mar 5, 2026 | Washburn Theodore James Jr.officer: Principal Accounting Officer | Sell | 5,272 | $28.88 |
| Jan 7, 2026 | Milanova Tsvetaofficer: Chief Commercial Officer | Option | 8,475 | — |
| Jan 7, 2026 | Milanova Tsvetaofficer: Chief Commercial Officer | Sell | 2,872 | $27.02 |
| Jan 2, 2026 | Gheuens Sarahofficer: Chief Medical Officer | Option | 6,000 | — |
| Jan 2, 2026 | Goff Briandirector, officer: Chief Executive Officer | Option | 12,750 | — |
| Jan 2, 2026 | Goff Briandirector, officer: Chief Executive Officer | Option | 25,528 | — |
| Jan 2, 2026 | Gheuens Sarahofficer: Chief Medical Officer | Sell | 2,932 | $27.09 |
| Jan 2, 2026 | Jones Ceciliaofficer: Chief Financial Officer | Option | 6,000 | — |
| Jan 2, 2026 | Milanova Tsvetaofficer: Chief Commercial Officer | Option | 6,000 | — |
| Jan 2, 2026 | Milanova Tsvetaofficer: Chief Commercial Officer | Sell | 2,932 | $27.09 |
| Jan 2, 2026 | Goff Briandirector, officer: Chief Executive Officer | Sell | 12,473 | $27.09 |
| Jan 2, 2026 | Goff Briandirector, officer: Chief Executive Officer | Sell | 6,230 | $27.09 |
| Jan 2, 2026 | Jones Ceciliaofficer: Chief Financial Officer | Sell | 2,932 | $27.09 |
| Jan 2, 2026 | Burns James Williamofficer: Chief Legal Officer | Sell | 2,932 | $27.09 |
Source: AGIO SEC Form 4 filings, latest Apr 6, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their AGIO positions over the last 6 months (SEC Form 13F).
Increased
185
New positions
84
Reduced
148
Sold out
84
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 5.8M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 5.8M | May 13, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 5.7M | May 15, 2026 |
| VANGUARD GROUP INC | Reduced | 5.6M | Jan 29, 2026 |
| BLACKROCK, INC. | Increased | 5.2M | Feb 12, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 5.2M | Feb 17, 2026 |
| STATE STREET CORP | Increased | 3.4M | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 3.2M | May 15, 2026 |
| STATE STREET CORP | Increased | 3.1M | Feb 13, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 3.0M | Feb 17, 2026 |
| ERSTE ASSET MANAGEMENT GMBH | Increased | 2.8M | Feb 11, 2026 |
| ERSTE ASSET MANAGEMENT GMBH | Reduced | 2.7M | May 11, 2026 |
| D. E. SHAW & CO., INC. | Increased | 2.7M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2.6M | May 15, 2026 |
| LYNX1 CAPITAL MANAGEMENT LP | Increased | 2.6M | May 4, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.